Adverum Biotechnologies Stock Target Price and Analyst Consensus
| ADVM Stock | USD 11.34 0.19 1.70% |
The current analyst and expert consensus on Adverum Biotechnologies is Strong Buy, with 5 strong buy opinions. The current projected Adverum Biotechnologies target price consensus is 4.25 with 6 analyst opinions. The most common way Adverum Biotechnologies analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Adverum Biotechnologies executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Adverum Biotechnologies. We strongly encourage you to use your own analysis of Adverum Biotechnologies to validate this buy or sell advice. Adverum Biotechnologies buy-or-sell recommendation module provides average expert sentiment on the projected Adverum Biotechnologies target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Adverum Biotechnologies to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
Lowest Forecast 3.87 | Highest Forecast 4.72 | Target Price 4.25 |
Adverum |
It's important to approach Adverum Biotechnologies' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Adverum Biotechnologies price targets
Adverum Biotechnologies' stock target price is an estimate of its future price, usually made by analysts. Using Adverum Biotechnologies' target price to determine if it is a suitable investment can be done through the following steps:- Look at Adverum Biotechnologies' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Adverum Biotechnologies' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Adverum Biotechnologies Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Adverum Biotechnologies is a key component of Adverum Biotechnologies valuation and have some predictive power on the future returns of a Adverum Biotechnologies.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adverum Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Momentum Invested over 50 shares | |
Check out Macroaxis Advice on Adverum Biotechnologies to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets |
The data published in Adverum Biotechnologies' official financial statements usually reflect Adverum Biotechnologies' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Adverum Biotechnologies. For example, before you start analyzing numbers published by Adverum accountants, it's critical to develop an understanding of what Adverum Biotechnologies' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Adverum Biotechnologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Adverum Biotechnologies' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Adverum Biotechnologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adverum Biotechnologies. Please utilize our Beneish M Score to check the likelihood of Adverum Biotechnologies' management manipulating its earnings.